Fundz

Nabla Bio Closes $11M Seed Financing Led By Khosla Ventures And Zetta Venture Partners

PRIVATEDec 06, 2021

Amount Raised

$11 Million

Round Type

Seed

BostonBiotechnologyData And AnalyticsScience And Engineering

Description

Nabla Bio, a next-generation antibody design company, announced the closing of a $11M Seed financing round. The round was co-led by Khosla Ventures and Zetta Venture Partners, with participation from Fifty Years, Cantos Ventures, and others.

Quick answer

Nabla Bio raised $11 Million in a Seed round, dated December 6, 2021. Nabla Bio is based in Boston, Massachusetts, United States.

How much did Nabla Bio raise?
Nabla Bio raised $11 Million in a Seed round on December 6, 2021.
What does Nabla Bio do?
Nabla Bio is an antibody design company.
Where is Nabla Bio based and how big is it?
Nabla Bio is based in Boston, Massachusetts, United States.
Who are the decision-makers at Nabla Bio?
Fundz holds 1 contact at Nabla Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Data And Analytics and Science And Engineering around the same time

Companies in the same sectors as Nabla Bio that raised within 45 days of this round, from Fundz verified event records.

  • Stilla Technologies raised an undisclosed amount on November 23, 2021.
  • Cardurion Pharmaceuticals raised an undisclosed amount on October 27, 2021.
  • Atom Computing raised $60M (Series B) on January 20, 2022.
  • Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
  • Ori Biotech raised $100M (Series B) on January 18, 2022.
  • Feldan Therapeutics raised an undisclosed amount (Funding Round) on January 18, 2022.

Who to call at Nabla Bio, and when

A new round usually means Nabla Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nabla Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nabla Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nabla Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nabla Bio

Location

Boston, Massachusetts, United States

About

Nabla Bio is an antibody design company. The company’s AI-first protein design platform enables rapid engineering of best-in-class antibody therapeutics. The foundational technology was developed by CEO Surge Biswas, academic Co-Founder George Church and their team at Harvard, and has advanced the field of machine learning-guided protein modeling and design. The company has a fully functional wet lab to complement its machine learning capabilities. Nabla Bio is based in Boston, MA.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nabla Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Nabla Bio's next move

See what Strategic adds

Nabla Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.